Transcription, RNA Processing and Non-coding RNA
RNA polymerases, promoters, inhibitors, activators and repressors, capping, splicing, editing, polyadenylation, RNA export, ribozymes, riboswitches and ncRNA.
- 23 min
On this page · 17 sections
- Prerequisites
- The Hook: A Mushroom, an Antibiotic and Three Polymerases
- Bacterial Transcription
- Eukaryotic Transcription
- Processing of Pre-mRNA
- Processing of rRNA and tRNA
- RNA Transport
- Ribozymes
- Riboswitches
- Non-coding RNA
- Memory Tricks
- Don’t Confuse
- Common Mistakes
- Practice
- Quick Revision Table
- Key Takeaways
- What’s Next
Prerequisites
- DNA Replication, Repair and Recombination — template-directed polymerisation, helicases and nucleases reappear here.
- Carbohydrates, Lipids, Nucleic Acids and Vitamins — RNA structure, the 2’-OH and A-form helices explain why RNA can fold and catalyse.
- Protein Structure, Conformation and Stability — DNA-binding motifs (helix-turn-helix, zinc finger, leucine zipper) of activators and repressors.
The Hook: A Mushroom, an Antibiotic and Three Polymerases
Bacterial Transcription
RNA polymerase
E. coli has a single RNA polymerase. The core enzyme is α₂ββ’ω: β’ binds DNA, β contains the active site with β’ and binds rifampicin, the α subunits assemble the enzyme and their C-terminal domains (αCTD) contact activators and the UP element. Adding a σ factor gives the holoenzyme, which recognises promoters. σ is released (or loosened) after initiation and recycled.
| σ factor | Genes | Promoter / note |
|---|---|---|
| σ⁷⁰ (RpoD) | Housekeeping | −35 TTGACA, −10 TATAAT (Pribnow box), spacer optimally 17 bp |
| σ³² (RpoH) | Heat shock | Different −35/−10 consensus |
| σ⁵⁴ (RpoN) | Nitrogen assimilation and others | −24/−12 elements; needs an ATP-hydrolysing enhancer-binding activator (e.g. NtrC) acting from a distance through DNA looping, like a eukaryotic enhancer |
| σˢ (RpoS, σ³⁸) | Stationary phase, general stress | |
| σ²⁸ (FliA) | Flagellar genes | |
| σᴱ (σ²⁴) | Envelope (extracytoplasmic) stress | Held by an anti-σ factor in the membrane |
The transcription cycle
- Closed complex: holoenzyme binds the −35 and −10 elements.
- Open complex: about 12–14 bp around the −10 region melt (the transcription bubble); no ATP is needed for melting.
- Abortive initiation: short transcripts (2–10 nt) are made and released repeatedly while the polymerase stays at the promoter, pulling downstream DNA into itself (scrunching).
- Promoter escape: once the RNA is about 10 nt long, σ contacts are broken and the elongation complex leaves.
- Elongation: the RNA–DNA hybrid in the bubble is about 8–9 bp; the polymerase moves at a few tens of nucleotides per second and can backtrack and cleave (GreA/GreB). NusA and NusG modulate pausing.
- Termination:
- Intrinsic (Rho-independent): a GC-rich inverted repeat forms a hairpin in the RNA, followed by a run of U residues; the weak rU·dA hybrid lets the RNA dissociate.
- Rho-dependent: Rho, a hexameric RNA–DNA helicase with ATPase activity, binds a C-rich, unstructured rut site on the RNA, translocates 5’ → 3’ and pulls the RNA off a paused polymerase. Rho cannot load where ribosomes are translating, which links termination to translation (polarity).
Promoter strength depends on how close −35 and −10 are to consensus, spacer length, and the presence of an AT-rich UP element upstream of −35 (bound by αCTD). Mutations that move a promoter towards consensus are up-promoter mutations; those away from it are down-promoter mutations.
Inhibitors of transcription
| Inhibitor | Target | Effect |
|---|---|---|
| Rifampicin | Bacterial RNA polymerase β subunit, in the channel next to the active site, blocking the path of the growing RNA | Blocks extension beyond 2–3 nt, so it inhibits initiation; an elongating polymerase is resistant |
| Streptolydigin | Bacterial β' | Blocks elongation |
| Fidaxomicin | Bacterial RNAP “switch region” | Blocks open complex formation |
| Actinomycin D | DNA (intercalates at G·C pairs) | Blocks elongation by all polymerases, bacterial and eukaryotic; low doses preferentially block Pol I (rRNA) |
| α-Amanitin | Largest subunit of eukaryotic Pol II (near the bridge helix) | Pol II very sensitive, Pol III moderately, Pol I resistant (animal cells) |
| Cordycepin (3’-deoxyadenosine) | Incorporated as 3’-dATP | Chain termination; also blocks poly(A) addition |
| DRB, flavopiridol | CDK9 of P-TEFb | Block Pol II pause release and productive elongation |
| Triptolide | XPB subunit of TFIIH | Blocks Pol II initiation |
Eukaryotic Transcription
Three nuclear RNA polymerases (and two plant-specific ones)
| Polymerase | Products | α-Amanitin | Location |
|---|---|---|---|
| Pol I | Large rRNA precursor (45S/47S in mammals → 18S, 5.8S, 28S) | Resistant | Nucleolus |
| Pol II | mRNA, most snRNAs (U1, U2, U4, U5), miRNA precursors, most lncRNAs | Very sensitive | Nucleoplasm |
| Pol III | tRNA, 5S rRNA, U6 snRNA, 7SL RNA (SRP), 7SK RNA | Moderately sensitive | Nucleoplasm |
| Pol IV, Pol V (plants) | siRNA precursors and scaffold transcripts for RNA-directed DNA methylation |
Pol III promoters are unusual: tRNA genes use internal promoters (A and B boxes inside the gene), 5S rRNA uses an internal control region bound by TFIIIA, and U6 uses an upstream, Pol II-like promoter with a TATA box.
The Pol II core promoter and general transcription factors
Core promoter elements: TATA box (consensus TATAAA, about 25–30 bp upstream of the start site), Inr (initiator, spanning the start site), DPE (downstream promoter element), BRE (TFIIB recognition element). Many genes, especially housekeeping genes with CpG islands, lack a TATA box.
| Factor | Function |
|---|---|
| TFIID | TBP (TATA-binding protein, binds the minor groove and bends DNA sharply) + TAFs (recognise Inr, DPE) |
| TFIIA | Stabilises TBP–DNA |
| TFIIB | Bridges TBP and Pol II; sets the start site |
| TFIIF | Brings Pol II to the promoter |
| TFIIE | Recruits TFIIH |
| TFIIH | XPB helicase/ATPase opens the promoter; CDK7 kinase phosphorylates the CTD at Ser5 (also an NER factor) |
Assembly order (textbook): TFIID → TFIIA → TFIIB → Pol II·TFIIF → TFIIE → TFIIH. Unlike bacterial open-complex formation, Pol II promoter opening needs ATP (TFIIH).
The CTD code
The C-terminal domain of the Pol II largest subunit has many repeats of the heptad Tyr-Ser-Pro-Thr-Ser-Pro-Ser (YSPTSPS).
graph LR
A["Unphosphorylated CTD
Pol II joins the
preinitiation complex"] --> B["Ser5-P (TFIIH/CDK7)
initiation, promoter escape,
capping enzymes recruited"]
B --> C["Promoter-proximal pause
(DSIF, NELF)"]
C --> D["P-TEFb (CDK9) phosphorylates
Ser2, DSIF, NELF
productive elongation"]
D --> E["Ser2-P high at 3' end
splicing and cleavage/
polyadenylation factors"]The CTD is the platform that couples transcription to capping, splicing and 3’ end formation. Pol I and Pol III have no CTD, and their products do not receive the m⁷G cap or a poly(A) tail.
Activators, repressors and the Mediator
Gene-specific regulators bind proximal promoter elements (GC box, CAAT box) and enhancers that can be thousands of base pairs away, upstream, downstream or in introns, in either orientation.
- Activators are modular: a DNA-binding domain (helix-turn-helix, homeodomain, zinc finger, basic leucine zipper, basic helix-loop-helix) plus an activation domain (acidic, glutamine-rich or proline-rich). Domain-swap experiments, for example the yeast Gal4 DNA-binding domain fused to another protein’s activation domain, show the two can be separated, which is the basis of the yeast two-hybrid assay.
- Activators work by recruiting Mediator (which contacts Pol II), general factors, and co-activators that modify chromatin (HATs such as CBP/p300, and ATP-dependent remodellers).
- Repressors compete with activators for binding, mask activation domains, block GTF assembly, or recruit co-repressors (HDACs, histone methyltransferases).
- Insulators (bound by CTCF in vertebrates) block enhancer–promoter communication across them and act as barriers to heterochromatin spread.
The detailed operon and eukaryotic regulatory circuits are on the regulation page.
Termination by the eukaryotic polymerases
- Pol I: a termination factor bound downstream of the rRNA unit.
- Pol III: a short run of T residues in the non-template strand; no hairpin needed.
- Pol II: coupled to cleavage and polyadenylation. In the torpedo model, the 5’→3’ exonuclease Xrn2 degrades the downstream RNA left attached to Pol II after cleavage, catches up and dislodges the polymerase; in the allosteric model, passing the poly(A) signal changes Pol II and its associated factors so it becomes termination-prone. Both contribute.
Processing of Pre-mRNA
5’ capping
Happens co-transcriptionally, very early (once the RNA is a few tens of nucleotides long and emerges from Pol II with Ser5-P CTD).
- RNA triphosphatase removes the γ-phosphate of the first nucleotide.
- Guanylyltransferase adds GMP (from GTP) in an unusual 5’–5’ triphosphate linkage.
- Guanine-N7 methyltransferase methylates the G with S-adenosylmethionine → cap 0 (m⁷GpppN).
- 2’-O-methylation of the first (cap 1) and second (cap 2) transcribed nucleotides in higher eukaryotes.
Functions: protects from 5’ exonucleases, binds the nuclear cap-binding complex (CBC: CBP80/CBP20) for splicing of the first intron and export, and binds eIF4E in the cytoplasm for translation initiation.
Splicing
Splice-site signals in a nuclear pre-mRNA intron:
- 5’ splice site: exon…AG|GURAGU…
- Branch point: an A typically 18–40 nt upstream of the 3’ splice site (yeast consensus UACUAAC)
- Polypyrimidine tract
- 3’ splice site: …YAG|exon
(GU–AG rule; a minor class uses AU–AC and other dinucleotides.)
Chemistry: two transesterifications
- The 2’-OH of the branch-point A attacks the phosphate at the 5’ splice site → exon 1 with a free 3’-OH + a lariat intermediate (the intron’s 5’ G joined to the branch A by a 2’–5’ phosphodiester; the branch A has three phosphodiester bonds).
- The 3’-OH of exon 1 attacks the phosphate at the 3’ splice site → ligated exons + released lariat intron (debranched and degraded).
The number of phosphodiester bonds is unchanged, so the chemistry needs no energy input; ATP is used by the DExD/H-box helicases that rearrange the spliceosome.
The spliceosome
| snRNP | Role |
|---|---|
| U1 | Base-pairs with the 5’ splice site (E complex) |
| U2 | Base-pairs with the branch site, bulging the branch A (A complex; ATP) |
| U2AF (protein, not an snRNP) | U2AF65 binds the polypyrimidine tract, U2AF35 the 3’ AG; SF1/BBP binds the branch point |
| U4/U6·U5 tri-snRNP | Joins (B complex); U4 is released and U6 displaces U1 at the 5’ splice site and pairs with U2 |
| U5 | Aligns the two exons for the second step |
| U2–U6 | Form the catalytic RNA core with Mg²⁺ ions: the spliceosome is a ribozyme |
The minor (U12-type) spliceosome uses U11, U12, U4atac, U6atac with U5.
Self-splicing introns
| Type | Nucleophile for step 1 | Product | Examples |
|---|---|---|---|
| Group I | 3’-OH of an exogenous guanosine (G, GMP, GDP or GTP) | Linear intron | Tetrahymena pre-rRNA, some organelle and phage genes |
| Group II | 2’-OH of an internal branch-point A | Lariat | Organelle genes in fungi and plants; mechanistically like the spliceosome |
| Nuclear pre-mRNA | 2’-OH of branch A | Lariat | Needs the spliceosome |
| Pre-tRNA (eukaryotic) | Protein enzymes: endonuclease + ligase | Introns next to the anticodon |
Alternative splicing (exon skipping, mutually exclusive exons, alternative 5’ or 3’ sites, intron retention) is regulated by SR proteins binding exonic splicing enhancers (usually promoting use of a site) and hnRNPs binding splicing silencers (usually repressing). Classic examples: Drosophila sex determination (Sex-lethal regulates transformer splicing; Tra and Tra2 regulate doublesex), and Drosophila Dscam, whose four clusters of alternative exons can in principle generate tens of thousands of isoforms. Splicing also deposits the exon junction complex (EJC) about 20–24 nt upstream of each exon–exon junction, which marks the mRNA for export and for nonsense-mediated decay (NMD): a stop codon more than about 50–55 nt upstream of the last exon junction is recognised as premature, and UPF proteins trigger decay.
RNA editing
A change in the RNA sequence after transcription, other than splicing and end processing.
| Type | Enzyme | Classic example | Result |
|---|---|---|---|
| C → U deamination | APOBEC1 (with a cofactor) | Apolipoprotein B mRNA in the intestine: a CAA (Gln) codon becomes UAA (stop) | Intestine makes the truncated apoB-48; liver makes full-length apoB-100 from the same gene |
| A → I deamination | ADAR (acts on dsRNA) | AMPA glutamate receptor subunit GluA2 (GluR-B) Q/R site: CAG → CIG, read as CGG (Arg) | Receptor channel becomes Ca²⁺-impermeable. Inosine is read as G |
| U insertion/deletion | Guide RNA-directed editosome | Trypanosome mitochondrial (kinetoplastid) mRNAs | Many Us inserted or deleted to create reading frames |
| C → U in organelles | Plant mitochondria and chloroplasts | Often restores conserved codons |
3’ end formation and polyadenylation
- Signal: AAUAAA about 10–30 nt upstream of the cleavage site, and a GU- or U-rich element downstream.
- CPSF binds AAUAAA (its CPSF-73 subunit is the endonuclease); CstF binds the GU-rich element; CFI and CFII assist; the CTD helps recruit them.
- Cleavage, then poly(A) polymerase (PAP) adds A residues (template-independent, ATP as substrate); nuclear poly(A)-binding protein (PABPN1) stimulates PAP and helps set the tail length (around 200–250 A in mammals).
- Cytoplasmic PABPC binds the tail, protects the mRNA and interacts with eIF4G (closed-loop translation).
- Exception: replication-dependent histone mRNAs are not polyadenylated; their 3’ end is a stem-loop bound by SLBP, made by U7 snRNP-directed cleavage.
- Alternative polyadenylation gives mRNAs with different 3’ UTRs (and so different miRNA sites and stabilities), or even different C-termini.
mRNA decay
Most cytoplasmic mRNAs are degraded by deadenylation (CCR4–NOT, PAN2–PAN3) followed by decapping (Dcp2) and 5’ → 3’ degradation by Xrn1, or by 3’ → 5’ degradation by the exosome. AU-rich elements (AUUUA repeats) in 3’ UTRs of cytokine and proto-oncogene mRNAs cause rapid decay.
Processing of rRNA and tRNA
- Bacteria: rRNA operons give a single precursor (16S, 23S, 5S and often tRNAs); RNase III cuts in double-stranded stems, then other nucleases trim.
- Eukaryotes: Pol I makes one precursor containing 18S, 5.8S and 28S (the 5S is made separately by Pol III); processing happens in the nucleolus, guided by snoRNAs: box C/D snoRNAs guide 2’-O-methylation, box H/ACA snoRNAs guide pseudouridylation.
- tRNA: RNase P (a ribozyme) cuts the 5’ leader; 3’ trailer removed by endonuclease/exonucleases; CCA added by tRNA nucleotidyltransferase if not encoded; many base modifications (dihydrouridine, pseudouridine, inosine at the wobble position in some tRNAs); some eukaryotic pre-tRNAs have introns removed by protein enzymes.
RNA Transport
All RNAs made in the nucleus must cross the nuclear pore complex.
| RNA | Export receptor | Ran-GTP dependent? |
|---|---|---|
| Bulk mRNA | NXF1–NXT1 (yeast Mex67–Mtr2), loaded by the TREX complex coupled to capping, splicing and 3’ processing | No; directionality from the cytoplasmic DEAD-box ATPase Dbp5/DDX19, which remodels the mRNP at the cytoplasmic face |
| tRNA | Exportin-t | Yes |
| pre-miRNA | Exportin-5 | Yes |
| Some snRNAs, rRNA subunits, unspliced HIV RNA (via Rev) | CRM1 (exportin-1) recognising leucine-rich nuclear export signals | Yes |
Pre-mRNAs with unspliced introns are normally retained in the nucleus. HIV overcomes this with the Rev protein, which binds the Rev response element (RRE) in its unspliced and partly spliced RNAs and recruits CRM1. Cytoplasmic mRNA localisation (for example ASH1 mRNA to the yeast bud tip, bicoid to the anterior of the Drosophila oocyte) uses 3’ UTR “zipcode” sequences and motor proteins.
Ribozymes
Catalytic RNAs. Discovered through the self-splicing Tetrahymena rRNA intron (Cech) and the RNA subunit of RNase P (Altman); the two shared the 1989 Nobel Prize in Chemistry.
| Ribozyme | Reaction |
|---|---|
| Group I and group II introns | Self-splicing by transesterification |
| RNase P RNA (M1 RNA in E. coli) | Cuts the 5’ leader of pre-tRNA; the RNA alone is catalytic in vitro at high Mg²⁺ |
| Hammerhead, hairpin, HDV ribozymes | Self-cleavage, producing a 2’,3’-cyclic phosphate and a 5’-OH; used in rolling-circle replication of viroids and satellite RNAs |
| Peptidyl transferase centre of the large-subunit rRNA (23S/28S) | Peptide bond formation; no protein within the immediate active site |
| Spliceosome (U2–U6 core) | Pre-mRNA splicing |
| glmS ribozyme | Self-cleaves when glucosamine-6-phosphate binds (also a riboswitch) |
RNA can catalyse because it folds into defined 3D structures, its 2’-OH can act as a nucleophile and its phosphates bind Mg²⁺ ions that stabilise transition states. This underlies the RNA world hypothesis.
Riboswitches
Structured elements, mostly in the 5’ UTRs of bacterial mRNAs, that bind a small metabolite directly, without any protein, and change gene expression.
- Aptamer domain: binds the ligand with high specificity.
- Expression platform: switches structure on binding.
| Mechanism | How |
|---|---|
| Transcription termination | Ligand binding favours a terminator hairpin over an antiterminator (or the reverse) |
| Translation initiation | Ligand binding sequesters (or exposes) the Shine–Dalgarno sequence |
| Self-cleavage | glmS ribozyme cleaves its own mRNA on GlcN6P binding |
| Splicing / 3’ processing | TPP riboswitches in fungi and plants control alternative splicing or polyadenylation |
Ligands include TPP, FMN, SAM, lysine, glycine (tandem aptamers), guanine and adenine, cobalamin and others. Most riboswitches are “off” switches that repress the genes for making the ligand when it is abundant: feedback without a protein repressor.
Non-coding RNA
graph TD
N["Non-coding RNA"] --> H["Housekeeping
rRNA, tRNA, snRNA,
snoRNA, RNase P, SRP 7SL,
telomerase RNA"]
N --> S["Small regulatory
miRNA, siRNA, piRNA;
bacterial sRNA"]
N --> L["Long non-coding
Xist, HOTAIR, MALAT1,
NEAT1, 7SK, enhancer RNAs"]miRNA, siRNA and piRNA
| Feature | miRNA | siRNA | piRNA |
|---|---|---|---|
| Source | Endogenous hairpin transcripts (Pol II) | Long dsRNA (viral, transgene, repeat) | Single-stranded precursors from piRNA clusters |
| Processing | Drosha–DGCR8 (nucleus) → pre-miRNA → Exportin-5 → Dicer (cytoplasm) | Dicer | Dicer-independent; ping-pong amplification |
| Length | About 21–23 nt | About 21–23 nt | Longer (about 24–31 nt), 2’-O-methylated 3’ end |
| Effector | Argonaute (AGO) in RISC | AGO2 (slicer) | PIWI proteins |
| Target pairing | Animals: seed (nt 2–8) with partial complementarity in 3’ UTRs → translational repression, deadenylation and decay. Plants: near-perfect → cleavage | Perfect → cleavage of target | Transposon transcripts |
| Main role | Fine-tuning hundreds of genes | Antiviral defence, experimental knockdown | Transposon silencing in the germline |
The first miRNA, lin-4, was found in C. elegans developmental timing; Victor Ambros and Gary Ruvkun received the 2024 Nobel Prize in Physiology or Medicine for the discovery of microRNA. RNA interference by dsRNA in C. elegans was reported by Fire and Mello (Nobel Prize 2006).
Other ncRNAs worth knowing
- Bacterial sRNAs: base-pair with target mRNAs, helped by the chaperone Hfq; for example RyhB (iron starvation) represses iron-using proteins, MicF represses the porin OmpF. 6S RNA mimics an open promoter and sequesters σ⁷⁰ holoenzyme in stationary phase. tmRNA rescues stalled ribosomes (see the translation page). CRISPR RNAs guide Cas nucleases.
- lncRNAs (longer than 200 nt): Xist coats the inactive X and recruits silencing complexes; HOTAIR (from the HOXC locus) represses HOXD genes in trans via PRC2; 7SK sequesters P-TEFb; MALAT1 and NEAT1 organise nuclear speckles and paraspeckles. Mechanisms: guides, scaffolds, decoys, and enhancer RNAs.
- snoRNAs (modification guides) and scaRNAs (Cajal body, snRNA modification).
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Rifampicin: binds RNAP β, blocks initiation | vs | Actinomycin D: binds DNA, blocks elongation in all cells |
| Rho-independent: hairpin + U-run | vs | Rho-dependent: C-rich rut site, ATP-driven helicase |
| σ⁷⁰: promoter melting without ATP | vs | σ⁵⁴: needs an ATP-hydrolysing enhancer-binding activator |
| TFIIH CDK7: Ser5-P (initiation) | vs | P-TEFb CDK9: Ser2-P (elongation) |
| Group I intron: exogenous G, linear intron | vs | Group II intron: internal A, lariat |
| Cap: 5’–5’ triphosphate, m⁷G | vs | Lariat: 2’–5’ phosphodiester at branch A |
| CPSF: binds AAUAAA | vs | CstF: binds downstream GU-rich element |
| mRNA export: NXF1, Ran-independent | vs | tRNA/pre-miRNA export: exportins, Ran-GTP-dependent |
| Ribozyme: RNA catalyses a reaction | vs | Riboswitch: RNA binds a metabolite to regulate a gene |
| miRNA: hairpin, seed pairing, repression | vs | siRNA: long dsRNA, perfect pairing, cleavage |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- Which snRNA base-pairs with the 5’ splice site first?
- What is the consensus −10 element of a σ⁷⁰ promoter?
- Which enzyme makes the 5’–5’ linkage in the mRNA cap?
Answers
- U1 snRNA (later replaced by U6).
- TATAAT (Pribnow box).
- Guanylyltransferase (capping enzyme), transferring GMP from GTP to the 5’-diphosphate end.
Level 2: Part B Style
Q1 (practice). Isolated mammalian nuclei are incubated with labelled UTP and a low concentration of α-amanitin that inhibits only the most sensitive polymerase. Which RNA would still be labelled normally?
- (a) pre-mRNA of a housekeeping gene
- (b) pri-miRNA
- (c) 45S pre-rRNA and pre-tRNA
- (d) U2 snRNA
Answer and explanation
(c). A low concentration inhibits Pol II only. Pol I (45S pre-rRNA) and Pol III (tRNA) continue. Pre-mRNA, pri-miRNA and U2 snRNA are Pol II products.
Q2 (practice). In a group I self-splicing reaction in vitro, the first nucleophile is:
- (a) the 2’-OH of an internal adenosine
- (b) the 3’-OH of a free guanosine nucleotide or nucleoside
- (c) the 3’-OH of the upstream exon
- (d) a water molecule activated by Mg²⁺
Answer and explanation
(b). Exogenous G binds a pocket in the intron and its 3’-OH attacks the 5’ splice site. The upstream exon’s 3’-OH attacks in the second step (c). (a) describes group II and nuclear introns.
Q3 (practice). A point mutation changes the AAUAAA sequence in the 3’ UTR of a gene to AAGAAA. The most likely immediate effect is:
- (a) failure of cap formation
- (b) inefficient cleavage and polyadenylation, with reduced levels of mature mRNA
- (c) retention of the first intron
- (d) a frameshift in the protein
Answer and explanation
(b). AAUAAA is the CPSF-binding polyadenylation signal; the AAUAAA → AAGAAA change disrupts recognition, so 3’ end formation and termination are impaired and less mature, exported, stable mRNA is made. It is in the 3’ UTR, so the coding frame is unchanged.
Q4 (practice). A bacterial operon for lysine biosynthesis has a structured 5’ leader. Adding lysine to the medium causes premature termination of transcription within the leader in a purified system containing only DNA, RNA polymerase, NTPs and lysine. The leader most likely contains:
- (a) an attenuator that depends on ribosome stalling
- (b) a riboswitch
- (c) a binding site for a lysine-activated repressor protein
- (d) a group II intron
Answer and explanation
(b). No ribosomes and no regulatory protein are present, yet lysine acts directly on the nascent RNA: the aptamer binds lysine and favours a terminator. Attenuation (a) needs translating ribosomes; (c) needs a protein.
Level 3: Part C Style
Q1 (practice). RT-PCR with primers in exon 2 and exon 4 of a gene amplifies two products from brain RNA: 420 bp and 300 bp. Exon 3 is 120 bp. From liver RNA only the 420 bp product appears. Sequencing of the 420 bp product from brain shows a G at one position where the genomic DNA has an A. Which conclusions are justified?
(A) Exon 3 is alternatively skipped in brain. (B) The skipping preserves the reading frame. (C) The A → G difference most likely reflects ADAR editing. (D) Liver lacks the U2 snRNP.
- (a) A, B and C
- (b) A and D only
- (c) B and C only
- (d) A, B, C and D
Answer and worked solution
(a) A, B and C.
- 420 − 300 = 120 bp = exon 3, so the shorter product lacks exon 3: exon skipping in brain (A).
- 120 is divisible by 3 (120/3 = 40 codons), so skipping removes 40 amino acids without a frameshift (B).
- Inosine is read as G by reverse transcriptase, so an A in DNA appearing as G in cDNA is the signature of A-to-I editing (C).
- (D) is absurd: without U2 there would be no splicing at all, and liver clearly splices exons 2-3-4.
Q2 (practice). A 60 kb eukaryotic gene is transcribed by Pol II at 40 nt s⁻¹ (assume a constant rate). (i) How long does it take to transcribe the gene once? (ii) If transcription stops completely at time zero after flavopiridol addition, but polymerases already past the pause site continue, how long until the last polymerase finishes? (iii) A Drosophila gene has four alternative exon clusters containing 12, 48, 33 and 2 mutually exclusive alternatives. How many distinct mRNAs can, in principle, be made?
Answer and worked solution
(i) \(t = 60{,}000/40 = 1500\ \text{s} = 25\ \text{min}\).
(ii) Flavopiridol inhibits P-TEFb, so no new polymerase is released from the promoter-proximal pause; those already elongating continue. The last one released just before addition must travel nearly the full 60 kb: about 25 min. Measuring how the “wave” of loss moves along a gene after such a block is one way to estimate elongation rates.
(iii) Mutually exclusive choices multiply: \(12 \times 48 \times 33 \times 2 = 38{,}016\) mRNAs (this is the Dscam calculation).
Q3 (practice). In a reporter assay, a luciferase gene carries a 3’ UTR with a 7-nt sequence perfectly complementary to nucleotides 2–8 of an miRNA. Cells are co-transfected with the reporter and the miRNA (or a control). Results (relative luciferase activity; relative luciferase mRNA by qPCR):
| Condition | Activity | mRNA |
|---|---|---|
| Control RNA | 1.00 | 1.00 |
| miRNA | 0.35 | 0.55 |
| miRNA + reporter with seed site mutated | 0.98 | 1.02 |
| siRNA fully complementary to a coding-region site | 0.10 | 0.08 |
Interpret the results.
Answer and worked solution
- The miRNA represses the reporter through the seed site: mutating the site abolishes repression (0.98).
- Repression involves both mRNA loss (0.55, consistent with deadenylation and decay) and reduced translation of the remaining mRNA: protein per mRNA = 0.35/0.55 ≈ 0.64.
- The fully complementary siRNA reduces mRNA and activity in parallel (0.08 and 0.10; activity per mRNA ≈ 1.25, i.e. no extra translational effect): AGO2 slicing destroys the mRNA.
- Conclusion: seed-matched animal miRNAs act by combined destabilisation and translational repression, whereas perfect complementarity gives cleavage.
Quick Revision Table
| Item | Fact |
|---|---|
| E. coli RNAP | Core α₂ββ’ω + σ; rifampicin binds β |
| σ⁷⁰ promoter | −35 TTGACA, −10 TATAAT, 17 bp spacer; UP element binds αCTD |
| σ⁵⁴ | −24/−12; needs ATP-driven enhancer-binding activator (NtrC) |
| Termination | Intrinsic: GC hairpin + U-run; Rho: rut site, ATP helicase |
| Inhibitors | Rifampicin (initiation, bacteria); actinomycin D (DNA, elongation, all); α-amanitin (Pol II > III > I); cordycepin (chain terminator); DRB/flavopiridol (CDK9) |
| Pol I / II / III | rRNA 18S-5.8S-28S / mRNA, miRNA, most snRNA / tRNA, 5S, U6, 7SL |
| Pol II GTFs | TFIID (TBP + TAFs), IIA, IIB, IIF, IIE, IIH (XPB helicase, CDK7) |
| CTD | YSPTSPS repeats; Ser5-P initiation/capping; Ser2-P elongation/3’ end |
| Activators | Modular DBD + AD; Mediator; co-activators HAT, remodellers |
| Cap | m⁷GpppN; 5’–5’ triphosphate; triphosphatase, guanylyltransferase, N7-MTase (SAM) |
| Splicing | GU…A…AG; 2 transesterifications; lariat 2’–5’; U1, U2, U4/U6, U5 |
| Self-splicing | Group I exogenous G, linear; group II branch A, lariat |
| NMD | Stop codon >50–55 nt upstream of last exon junction; EJC, UPF |
| Editing | apoB C→U (APOBEC1), apoB-48 in intestine; A→I (ADAR) read as G |
| Poly(A) | AAUAAA (CPSF) + GU-rich (CstF); PAP; histone mRNAs lack poly(A) |
| Export | mRNA NXF1 (Ran-independent); tRNA exportin-t; pre-miRNA exportin-5; CRM1 for NES and HIV Rev |
| snoRNAs | C/D → 2’-O-methylation; H/ACA → pseudouridylation |
| Ribozymes | Group I/II, RNase P, hammerhead/hairpin/HDV, rRNA peptidyl transferase, spliceosome, glmS |
| Riboswitches | Aptamer + expression platform; TPP, FMN, SAM, Lys, Gly, purines; control termination or SD access |
| miRNA pathway | Drosha–DGCR8 → exportin-5 → Dicer → AGO; seed nt 2–8 |
| piRNA | Dicer-independent, PIWI, germline transposon silencing |
Key Takeaways
What’s Next
- Translation, Protein Processing and Degradation — what happens to the mature mRNA once it reaches the cytoplasm.
- Regulation of Gene Expression and Epigenetics — operons, λ, eukaryotic activators and chromatin built on the machinery on this page.
- DNA Replication, Repair and Recombination — TFIIH links transcription to nucleotide excision repair.
- Quick Revision — the whole unit on one page.